Literature DB >> 31378104

Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New American College of Cardiology/American Heart Association Classification of Hypertension.

Yi-Bang Cheng1, Lutgarde Thijs2, Zhen-Yu Zhang2, Masahiro Kikuya3, Wen-Yi Yang2, Jesus D Melgarejo4, José Boggia5, Fang-Fei Wei2, Tine W Hansen6, Cai-Guo Yu2, Kei Asayama3,7, Takayoshi Ohkubo3,7, Eamon Dolan8, Katarzyna Stolarz-Skrzypek9, Sofia Malyutina10, Edoardo Casiglia11, Lars Lind12, Jan Filipovský13, Gladys E Maestre4,14, Yutaka Imai7, Kalina Kawecka-Jaszcz9, Edgardo Sandoya15, Krzysztof Narkiewicz16, Yan Li1, Eoin O'Brien17, Ji-Guang Wang1, Jan A Staessen2,18.   

Abstract

The new American College of Cardiology/American Heart Association guideline reclassified office blood pressure and proposed thresholds for ambulatory blood pressure (ABP). We derived outcome-driven ABP thresholds corresponding with the new office blood pressure categories. We performed 24-hour ABP monitoring in 11 152 participants (48.9% women; mean age, 53.0 years) representative of 13 populations. We determined ABP thresholds resulting in multivariable-adjusted 10-year risks similar to those associated with elevated office blood pressure (120/80 mm Hg) and stages 1 and 2 of office hypertension (130/80 and 140/90 mm Hg). Over 13.9 years (median), 2728 (rate per 1000 person-years, 17.9) people died, 1033 (6.8) from cardiovascular disease; furthermore, 1988 (13.8), 893 (6.0), and 795 (5.4) cardiovascular and coronary events and strokes occurred. Using a composite cardiovascular end point, systolic/diastolic outcome-driven thresholds indicating elevated 24-hour, daytime, and nighttime ABP were 117.9/75.2, 121.4/79.6, and 105.3/66.2 mm Hg. For stages 1 and 2 ambulatory hypertension, thresholds were 123.3/75.2 and 128.7/80.7 mm Hg for 24-hour ABP, 128.5/79.6 and 135.6/87.1 mm Hg for daytime ABP, and 111.7/66.2 and 118.1/72.5 mm Hg for nighttime ABP. ABP thresholds derived from other end points were similar. After rounding, approximate thresholds for elevated 24-hour, daytime, and nighttime ABP were 120/75, 120/80, and 105/65 mm Hg, and for stages 1 and 2, ambulatory hypertension 125/75 and 130/80 mm Hg, 130/80 and 135/85 mm Hg, and 110/65 and 120/70 mm Hg. Outcome-driven ABP thresholds corresponding to elevated blood pressure and stages 1 and 2 of hypertension are similar to those proposed by the current American College of Cardiology/American Heart Association guideline.

Entities:  

Keywords:  United States; blood pressure monitoring, ambulatory; hypertension

Mesh:

Year:  2019        PMID: 31378104      PMCID: PMC6739146          DOI: 10.1161/HYPERTENSIONAHA.119.13512

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  24 in total

1.  Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension.

Authors:  Tatiana Kuznetsova; Jan A Staessen; Kalina Kawecka-Jaszcz; Speranta Babeanu; Edoardo Casiglia; Jan Filipovsky; Choudomir Nachev; Yuri Nikitin; Jan Peleskã; Eoin O'Brien
Journal:  Blood Press Monit       Date:  2002-08       Impact factor: 1.444

2.  Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study.

Authors:  Teemu J Niiranen; Marjo-Riitta Hänninen; Jouni Johansson; Antti Reunanen; Antti M Jula
Journal:  Hypertension       Date:  2010-04-12       Impact factor: 10.190

3.  Evaluation of the DINAMAP blood pressure monitor in an ambulatory primary care setting.

Authors:  S Ornstein; G Markert; L Litchfield; L Zemp
Journal:  J Fam Pract       Date:  1988-05       Impact factor: 0.493

4.  Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals.

Authors:  Tine W Hansen; Masahiro Kikuya; Lutgarde Thijs; Kristina Björklund-Bodegård; Tatiana Kuznetsova; Takayoshi Ohkubo; Tom Richart; Christian Torp-Pedersen; Lars Lind; Jørgen Jeppesen; Hans Ibsen; Yutaka Imai; Jan A Staessen
Journal:  J Hypertens       Date:  2007-08       Impact factor: 4.844

5.  Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies.

Authors:  J A Staessen; R H Fagard; P J Lijnen; L Thijs; R Van Hoof; A K Amery
Journal:  Am J Cardiol       Date:  1991-04-01       Impact factor: 2.778

6.  Short-term and long-term repeatability of the morning blood pressure in older patients with isolated systolic hypertension.

Authors:  Barbara Wizner; Dirk G Dechering; Lutgarde Thijs; Neil Atkins; Robert Fagard; Eoin O'Brien; Peter W de Leeuw; Gianfranco Parati; Paolo Palatini; Denis Clement; Tomasz Grodzicki; Kazuomi Kario; Jan A Staessen
Journal:  J Hypertens       Date:  2008-07       Impact factor: 4.844

7.  Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study.

Authors:  T Ohkubo; Y Imai; I Tsuji; K Nagai; S Ito; H Satoh; S Hisamichi
Journal:  Hypertension       Date:  1998-08       Impact factor: 10.190

8.  Thresholds for conventional and home blood pressure by sex and age in 5018 participants from 5 populations.

Authors:  Kyoko Nomura; Kei Asayama; Lutgarde Thijs; Teemu J Niiranen; Inés Lujambio; José Boggia; Atsushi Hozawa; Takayoshi Ohkubo; Azusa Hara; Jouni K Johansson; Edgardo Sandoya; Anastasios Kollias; George S Stergiou; Ichiro Tsuji; Antti M Jula; Yutaka Imai; Jan A Staessen
Journal:  Hypertension       Date:  2014-06-30       Impact factor: 10.190

9.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Circulation       Date:  2018-10-23       Impact factor: 29.690

10.  Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama.

Authors:  T Ohkubo; Y Imai; I Tsuji; K Nagai; N Watanabe; N Minami; O Itoh; T Bando; M Sakuma; A Fukao; H Satoh; S Hisamichi; K Abe
Journal:  J Hypertens       Date:  1997-04       Impact factor: 4.844

View more
  7 in total

Review 1.  High Blood Pressure in Children and Adolescents: Current Perspectives and Strategies to Improve Future Kidney and Cardiovascular Health.

Authors:  Cal H Robinson; Rahul Chanchlani
Journal:  Kidney Int Rep       Date:  2022-03-01

2.  2018 American Heart Association redefinition of resistant hypertension: Major adverse cardiovascular and renal events.

Authors:  Robert M Carey
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-10-15       Impact factor: 3.738

Review 3.  Pediatric Ambulatory Blood Pressure Classification: The Case for a Change.

Authors:  Mark Mitsnefes; Joseph T Flynn; Tammy Brady; Carissa Baker-Smith; Stephen R Daniels; Laura L Hayman; Andrew Tran; Justin P Zachariah; Elaine M Urbina
Journal:  Hypertension       Date:  2021-10-04       Impact factor: 9.897

4.  Two-Year Responses of Office and Ambulatory Blood Pressure to First Occupational Lead Exposure.

Authors:  Yu-Ling Yu; Wen-Yi Yang; Lutgarde Thijs; Jesus D Melgarejo; Cai-Guo Yu; Dong-Mei Wei; Fang-Fei Wei; Tim S Nawrot; Zhen-Yu Zhang; Jan A Staessen
Journal:  Hypertension       Date:  2020-09-09       Impact factor: 10.190

5.  Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension.

Authors:  Qi-Fang Huang; Wen-Yi Yang; Kei Asayama; Zhen-Yu Zhang; Lutgarde Thijs; Yan Li; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2021-01-04       Impact factor: 10.190

6.  Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure.

Authors:  Yi-Bang Cheng; Lutgarde Thijs; Lucas S Aparicio; Qi-Fang Huang; Fang-Fei Wei; Yu-Ling Yu; Jessica Barochiner; Chang-Sheng Sheng; Wen-Yi Yang; Teemu J Niiranen; José Boggia; Zhen-Yu Zhang; Katarzyna Stolarz-Skrzypek; Natasza Gilis-Malinowska; Valérie Tikhonoff; Wiktoria Wojciechowska; Edoardo Casiglia; Krzysztof Narkiewicz; Jan Filipovský; Kalina Kawecka-Jaszcz; Ji-Guang Wang; Yan Li; Jan A Staessen
Journal:  Hypertension       Date:  2022-03-04       Impact factor: 10.190

Review 7.  Guideline-Driven Management of Hypertension: An Evidence-Based Update.

Authors:  Robert M Carey; Jackson T Wright; Sandra J Taler; Paul K Whelton
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.